Silence Therapeutics’ $120 Million Private Placement

Foley & Larder LLP represented investor TCG Crossover. Silence Therapeutics plc (Nasdaq: SLN), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

This content is for Standard 1 Year members only.
Login Join Now